Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Category: FDA

3 5/23/2016

Inside the Sausage Factory of Drug Approval: Nuplazid (pimavanserin) coverage didn’t inspect closely enough

8 4/20/2016

Media mystery: Why did journalists ignore an important study on a costly, harmful back pain procedure?

4 3/16/2016

Coverage of Amarin off-label promotion agreement should have acknowledged deadly history of such marketing

1 2/29/2016

Precision Medicine at one year: A soaring White House summit and the potholes ahead

7 2/10/2016

Groups push pharma agenda under the guise of patient advocacy

1/15/2016

Faulty medical devices stay on the market even after manufacturers know there are problems

3 1/7/2016

“Thousands of lives lost”? Why calls for faster drug approvals need more scrutiny

5 1/5/2016

FDA teams up with medical device industry to write 21st Century Cures Act

9 12/16/2015

Opdivo ads vs. the reality of stage IV cancer treatment

5 11/19/2015

Media ignore impact of unsafe medical devices — unless the company CEO is a celebrity billionaire like Elizabeth Holmes